These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1568178)

  • 1. Proliferative activity in thyroid tumors.
    Yoshida A; Kamma H; Asaga T; Masuzawa C; Kawahara S; Mimura T; Ito K
    Cancer; 1992 May; 69(10):2548-52. PubMed ID: 1568178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors.
    Erickson LA; Jin L; Wollan PC; Thompson GB; van Heerden J; Lloyd RV
    Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of p27KIP1 and Ki67/Mib1 labeling index support the classification of thyroid carcinoma into prognostically relevant categories.
    Tallini G; Garcia-Rostan G; Herrero A; Zelterman D; Viale G; Bosari S; Carcangiu ML
    Am J Surg Pathol; 1999 Jun; 23(6):678-85. PubMed ID: 10366150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Pax-8, p53 and bcl-2 in human benign and malignant thyroid diseases.
    Puglisi F; Cesselli D; Damante G; Pellizzari L; Beltrami CA; Di Loreto C
    Anticancer Res; 2000; 20(1A):311-6. PubMed ID: 10769673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytokeratin expression of benign and malignant epithelial thyroid gland tumors. An immunohistologic study of 154 neoplasms using 8 different monoclonal cytokeratin antibodies].
    Schröder S; Wodzynski A; Padberg B
    Pathologe; 1996 Nov; 17(6):425-32. PubMed ID: 9082363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis and proliferative activity in thyroid tumors.
    Yoshida A; Nakamura Y; Imada T; Asaga T; Shimizu A; Harada M
    Surg Today; 1999; 29(3):204-8. PubMed ID: 10192728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of Leu-7 antigen (HNK-1) in thyroid tumors: its usefulness as a diagnostic marker for follicular and papillary carcinomas.
    Ghali VS; Jimenez EJ; Garcia RL
    Hum Pathol; 1992 Jan; 23(1):21-5. PubMed ID: 1371984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of the MIB-1 proliferative markers in the diagnosis and prognosis of tumors of the thyroid gland].
    Ludvíková M; Ryska A; Hovorková E; Pikner R
    Cesk Patol; 2002 Jan; 38(1):4-10. PubMed ID: 11933461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An immunohistochemical study of leu 7 and PCNA expression in thyroid neoplasms.
    Fucich LF; Freeman SM; Marrogi AJ
    Biotech Histochem; 1996 Nov; 71(6):298-303. PubMed ID: 8957557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intercellular adhesion molecule-1 (ICAM-1) immunoreactivity in well-differentiated thyroid papillary carcinomas.
    Tanda F; Cossu A; Bosincu L; Manca A; Ibba M; Massarelli G
    Mod Pathol; 1996 Jan; 9(1):53-6. PubMed ID: 8821957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical detection of p53 in differentiated, poorly differentiated and undifferentiated carcinomas of the thyroid.
    Soares P; Cameselle-Teijeiro J; Sobrinho-Simões M
    Histopathology; 1994 Mar; 24(3):205-10. PubMed ID: 8200621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies.
    Buergy D; Weber T; Maurer GD; Mudduluru G; Medved F; Leupold JH; Brauckhoff M; Post S; Dralle H; Allgayer H
    Int J Cancer; 2009 Aug; 125(4):894-901. PubMed ID: 19480010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant correlation of telomerase activity in thyroid papillary carcinomas with cell differentiation, proliferation and extrathyroidal extension.
    Okayasu I; Osakabe T; Fujiwara M; Fukuda H; Kato M; Oshimura M
    Jpn J Cancer Res; 1997 Oct; 88(10):965-70. PubMed ID: 9414658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical study of estrogen receptors and the responsiveness to estrogen in papillary thyroid carcinoma.
    Inoue H; Oshimo K; Miki H; Kawano M; Monden Y
    Cancer; 1993 Aug; 72(4):1364-8. PubMed ID: 8339226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis of the follicular variant of papillary thyroid carcinoma. Significance of immunohistochemistry].
    Guyétant S; Michalak S; Valo I; Saint-André JP
    Ann Pathol; 2003 Feb; 23(1):11-20. PubMed ID: 12743496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: a potential role in tumor metastasis.
    Xu X; Quiros RM; Maxhimer JB; Jiang P; Marcinek R; Ain KB; Platt JL; Shen J; Gattuso P; Prinz RA
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5968-79. PubMed ID: 14676122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood group antigens in differentiated thyroid neoplasms.
    González-Cámpora R; García-Sanatana JA; Jordà i Heras MM; Salaverri CO; Vázquez-Ramírez FJ; Argueta-Manzano OE; Galera-Davidson H
    Arch Pathol Lab Med; 1998 Nov; 122(11):957-65. PubMed ID: 9822123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical demonstration of ceruloplasmin in follicular adenomas and thyroid carcinomas.
    Tuccari G; Barresi G
    Histopathology; 1987 Jul; 11(7):723-31. PubMed ID: 3623436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinicopathologic analysis of 487 thyroid tumors].
    Cao XX; Gao LX; Wu X; Sha WX; Deng YJ
    Zhonghua Zhong Liu Za Zhi; 1987 Sep; 9(5):362-4, 19. PubMed ID: 3452528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical study of type-1 blood antigen expressions in thyroid tumors: the significance for papillary carcinomas.
    Kamoshida S; Ogane N; Yasuda M; Muramatsu T; Bessho T; Kajiwara H; Osamura RY
    Mod Pathol; 2000 Jul; 13(7):736-41. PubMed ID: 10912932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.